SOLUTION SHEET Why Phase I Trials Succeed With Medrio The Medrio Difference for Early Phase Trials Early Phase Trials Phase I clinical trials represent a major milestone in a new medical product’s journey from lab to market. The insights gathered from testing a product on humans is key to determining its viability as a treatment option and sets the tone for the whole research process. When early phase studies experience issues with site selection, recruitment, patient safety, and inefficient trial processes, it can result in costly delays to FDA submission and market arrival. Sponsors, CROs, and study managers need a flexible, unified eClinical suite to sprint their Phase 1 studies and ensure success all the way to final market approval.

Medrio is Designed to Sprint Your Studies Medrio eCRF Build Medrio Edit Check Build Medrio Deploy Competitor eCRF Build Competitor Edit Check Build Competitor Deploy A Faster, More Flexible Path to Deployment Success in early phase trials can lay the foundation for subsequent phases. Our flexible, integrated solutions were designed to reduce inefficiencies that result in lengthy and costly delays to sponsors. Build, test, and deploy your study in days, not months, with our intuitive point-and-click interface. Watch timelines continue to shorten as you leverage our extensive library of reusable...

Maintain Control of Mid-Study Changes Mid-study changes are commonplace in Phase I studies, and researchers need an efficient way to handle them without system downtime. Medrio makes it possible to review and deploy changes safely from a test environment to the live study in a matter of clicks without vendor reliance, downtime, pesky database migrations, or hidden fees. Practical Pricing for Every Phase Our straightforward, transparent pricing model is ideal for fast-moving Phase I studies. Lower your cost of ownership with pricing based on your specific site, subject, and timing needs Keep your...